Concepedia

Kate Luisi

KL

3

Publications

248

Citations

3

H-Index

2017

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

Kate Luisi is an author at GlaxoSmithKline (United States) specializing in immunodominance, viral immunity, and immunoengineering.

ORCID

Top concepts

Publications per year

2017–2022

3

Publications

3

Structural basis for potent antibody-mediated neutralization of human cytomegalovirus

Sumana Chandramouli, E. Malito, Tuong-Vi Nguyen et al. · Science Immunology · 2017 · 89 citations

, , +18

A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models

Giulietta Maruggi, Corey P. Mallett, Jason W. Westerbeck et al. · Molecular Therapy · 2022 · 80 citations · Full text

Development of a potent Zika virus vaccine using self-amplifying messenger RNA

Kate Luisi, Kaitlyn M. Morabito, Katherine E. Burgomaster et al. · Science Advances · 2020 · 79 citations · Full text

Rows per page

1–3 of 3